Literature DB >> 16777098

Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.

Tanya Pfeiffer1, Thorsten Pisch, Gerard Devitt, Denise Holtkotte, Valerie Bosch.   

Abstract

In certain cell systems, exchange of the human immunodeficiency virus (HIV) Env signal peptide (SP) sequence with that of heterologous SPs has been shown to increase gp120 transport and secretion. Here we demonstrate that exchange of the HIV-Env-SP with those from erythropoietin or tissue plasminogen activator in the proviral context does not increase wild-type membrane-bound Env expression or incorporation into released virions. In fact, virion infectivity was decreased. These infectivity decreases were largely due to effects on Env transport and/or function and only to a minor extent to cis effects as a result of the sequence exchanges themselves. Thus, in fact, it is not advantageous to employ heterologous SPs to achieve high-level expression of functional cell surface membrane- or virion-associated HIV-Env.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777098     DOI: 10.1016/j.febslet.2006.05.070

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  A comprehensive in silico characterization of bacterial signal peptides for the excretory production of Anabaena variabilis phenylalanine ammonia lyase in Escherichia coli.

Authors:  Hajar Owji; Shiva Hemmati
Journal:  3 Biotech       Date:  2018-11-16       Impact factor: 2.406

2.  Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

Authors:  Christine Goffinet; Sarah Schmidt; Christian Kern; Lena Oberbremer; Oliver T Keppler
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.

Authors:  Arnab Basu; Tatsuo Kanda; Aster Beyene; Kousuke Saito; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

4.  Stable expression and secretion of polyhydroxybutyrate depolymerase of Paucimonas lemoignei in Escherichia coli.

Authors:  Se Whan Park; Moon Gyu Chung; Hwa Young Lee; Jeong Yoon Kim; Young Ha Rhee
Journal:  J Microbiol       Date:  2008-12-24       Impact factor: 3.422

5.  β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.

Authors:  Hanna-Mari Tervo; Stefanie Homann; Ina Ambiel; Joëlle V Fritz; Oliver T Fackler; Oliver T Keppler
Journal:  Retrovirology       Date:  2011-02-10       Impact factor: 4.602

6.  A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.

Authors:  Mohammed Asmal; Ina Hellmann; Weimin Liu; Brandon F Keele; Alan S Perelson; Tanmoy Bhattacharya; S Gnanakaran; Marcus Daniels; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw; Norman L Letvin
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

7.  Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120.

Authors:  Jason Yolitz; Catherine Schwing; Julia Chang; Donald Van Ryk; Fatima Nawaz; Danlan Wei; Claudia Cicala; James Arthos; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

8.  Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.

Authors:  Flavia Chiuppesi; Felix Wussow; Louise Scharf; Heidi Contreras; Han Gao; Zhuo Meng; Jenny Nguyen; Peter A Barry; Pamela J Bjorkman; Don J Diamond
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

9.  Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide.

Authors:  Erik Lee Snapp; Nicholas McCaul; Matthias Quandte; Zuzana Cabartova; Ilja Bontjer; Carolina Källgren; IngMarie Nilsson; Aafke Land; Gunnar von Heijne; Rogier W Sanders; Ineke Braakman
Journal:  Elife       Date:  2017-07-28       Impact factor: 8.140

10.  Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa.

Authors:  Graeme B Jacobs; Stefanie Bock; Anita Schuch; Rebecca Moschall; Eva-Maria Schrom; Juliane Zahn; Christian Reuter; Wolfgang Preiser; Axel Rethwilm; Susan Engelbrecht; Thomas Kerkau; Jochen Bodem
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.